Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)

Phase: PHASE1 | Sponsor: Johns Hopkins University | Compound: Psilocybin

Status

recruiting

Institution

Johns Hopkins University

Start date

2025-09-17

End date

2029-08-01

Registry ID

NCT06989957

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.